Carcinoma, Hepatocellular

"Carcinoma, Hepatocellular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Descriptor ID	D006528
MeSH Number(s)	C04.557.470.200.025.255 C04.588.274.623.160 C06.301.623.160 C06.552.697.160
Concept/Terms	Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinomas, Hepatocellular Hepatocellular Carcinomas Liver Cell Carcinoma, Adult Liver Cancer, Adult Adult Liver Cancer Adult Liver Cancers Cancer, Adult Liver Cancers, Adult Liver Liver Cancers, Adult Liver Cell Carcinoma Carcinoma, Liver Cell Carcinomas, Liver Cell Cell Carcinoma, Liver Cell Carcinomas, Liver Liver Cell Carcinomas Hepatocellular Carcinoma Hepatoma Hepatomas

Below are MeSH descriptors whose meaning is more general than "Carcinoma, Hepatocellular".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Adenocarcinoma [C04.557.470.200.025]
Carcinoma, Hepatocellular [C04.557.470.200.025.255]
Neoplasms by Site [C04.588]
Digestive System Neoplasms [C04.588.274]
Liver Neoplasms [C04.588.274.623]
Carcinoma, Hepatocellular [C04.588.274.623.160]
Digestive System Diseases [C06]
Digestive System Neoplasms [C06.301]
Liver Neoplasms [C06.301.623]
Carcinoma, Hepatocellular [C06.301.623.160]
Liver Diseases [C06.552]
Liver Neoplasms [C06.552.697]
Carcinoma, Hepatocellular [C06.552.697.160]

Below are MeSH descriptors whose meaning is related to "Carcinoma, Hepatocellular".

Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Hepatocellular".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Carcinoma, Hepatocellular" by people in this website by year, and whether "Carcinoma, Hepatocellular" was a major or minor topic of these publications.

Bar chart showing 129 publications over 28 distinct years, with a maximum of 10 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	1	1
1997	1	0	1
1998	2	1	3
1999	0	1	1
2001	5	0	5
2002	2	3	5
2003	2	6	8
2004	0	1	1
2005	3	1	4
2006	1	0	1
2007	2	1	3
2008	6	1	7
2009	4	1	5
2010	5	2	7
2011	4	0	4
2012	5	0	5
2013	6	4	10
2014	2	0	2
2015	7	1	8
2016	6	1	7
2017	7	1	8
2018	6	1	7
2019	1	0	1
2020	3	0	3
2021	6	1	7
2022	6	0	6
2023	7	0	7
2024	2	0	2

Below are the most recent publications written about "Carcinoma, Hepatocellular" by people in Profiles.

Elaimy AL, El-Derany MO, James J, Wang Z, Pearson AN, Holcomb EA, Huber AK, Gij?n M, Bell HN, Sanghvi VR, Frankel TL, Su GL, Tapper EB, Tai AW, Ramnath N, Centonze CP, Dobrosotskaya I, Moeller JA, Bryant AK, Elliott DA, Choi E, Evans JR, Cuneo KC, Fitzgerald TJ, Wahl DR, Morgan MA, Chang DT, Wicha MS, Lawrence TS, Shah YM, Green MD. SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinoma. JCI Insight. 2024 Nov 08; 9(21).

View in: PubMed
Brancato V, Cerrone M, Garbino N, Salvatore M, Cavaliere C. Current status of magnetic resonance imaging radiomics in hepatocellular carcinoma: A quantitative review with Radiomics Quality Score. World J Gastroenterol. 2024 Jan 28; 30(4):381-417.

View in: PubMed
VoPham T, Cravero A, Feld LD, Green P, Feng Z, Berry K, Kim NJ, Vutien P, Mendoza JA, Ioannou GN. Associations of Race and Ethnicity with Hepatocellular Carcinoma, Decompensation, and Mortality in US Veterans with Cirrhosis. Cancer Epidemiol Biomarkers Prev. 2023 08 01; 32(8):1069-1078.

View in: PubMed
Marks RM, Fung A, Cruite I, Blevins K, Lalani T, Horvat N, Protopapas Z, Chaudhry H, Bijan B, Shiehmorteza M, Nepal P, Tang A. The adoption of LI-RADS: a survey of non-academic radiologists. Abdom Radiol (NY). 2023 08; 48(8):2514-2524.

View in: PubMed
Rasic G, Beaulieu-Jones BR, Chung SH, Romatoski KS, Kenzik K, Ng SC, Tseng JF, Sachs TE. The Impact of the COVID-19 Pandemic on Hepatocellular Carcinoma Time to Treatment Initiation: A National Cancer Database Study. Ann Surg Oncol. 2023 Jul; 30(7):4249-4259.

View in: PubMed
Qi S, Zhong Z, Zhu Y, Wang Y, Ma M, Wang Y, Liu X, Jin R, Jiao Z, Zhu R, Sha Z, Dang K, Liu Y, Lim DS, Mao J, Zhang L, Yu FX. Two Hippo signaling modules orchestrate liver size and tumorigenesis. EMBO J. 2023 06 01; 42(11):e112126.

View in: PubMed
Rasic G, de Geus SWL, Papageorge MV, Woods AP, Ng SC, McAneny D, Tseng JF, Sachs TE. Disparities in the Receipt of Recommended Curative Treatment for Patients with Early-Stage Hepatocellular Carcinoma. World J Surg. 2023 07; 47(7):1780-1789.

View in: PubMed
Rasic G, de Geus SWL, Beaulieu-Jones B, Kasumova GG, Kent TS, Ng SC, McAneny D, Tseng JF, Sachs TE. A nationwide propensity score analysis comparing ablation and resection for hepatocellular carcinoma. J Surg Oncol. 2023 Jun; 127(7):1125-1134.

View in: PubMed
Mou H, Eskiocak O, ?zler KA, Gorman M, Yue J, Jin Y, Wang Z, Gao Y, Janowitz T, Meyer HV, Yu T, Wilkinson JE, Kucukural A, Ozata DM, Beyaz S. CRISPR-induced exon skipping of ?-catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer. J Pathol. 2023 04; 259(4):415-427.

View in: PubMed
Daniell KM, Banson KM, Diamond BH, Sioshansi S. Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis. Curr Treat Options Oncol. 2022 12; 23(12):1761-1774.

View in: PubMed

People

Explore

Similar Concepts

Top Journals